Comparison of Patient-reported Outcomes for Rimegepant and Triptans in the 2023 US National Health and Wellness Survey
Clinical trial NCT06680206 · COMPLETED
Trial details
- NCT number
- NCT06680206
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-10-10
- Primary completion
- 2024-11-20
- Enrollment
- 1395
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.